Stockreport

Here's Why Pfizer Is Willing To Pay $500 Million For Novavax's Matrix-M [Seeking Alpha]

Novavax, Inc.  (NVAX) 
Last novavax, inc. earnings: 3/11 04:17 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.novavax.com/investor-relations
PDF NVAX receives $30M upfront, a potential $500M in milestones, and mid-single-digit royalties, with Pfizer assuming all development and commercialization risk. Matrix-M [Read more]